La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos pacientes con riesgo de #cáncer #gastrico sin tomar biopsias
Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2019 – Jul 2023Where it's discussed
-
X / Twitter36 posts
-
Facebook4 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions highlight enthusiasm for the non-invasive grading method introduced in the study, with phrases like 'can diagnose nearly 90%' and 'reduce the need for biopsies' indicating their perceived clinical value. The tone varies from supportive to cautiously optimistic, emphasizing the potential for improved patient management and early diagnosis, driven by mention of high sensitivity and specificity data and the clinical relevance of the endoscopic approach.
Most discussions express support or positive acknowledgment of the study, indicating general agreement on its importance and findings, such as references to the high sensitivity and specificity of the EGGIM method.
Posts show moderate to high curiosity, with mentions of potential clinical applications and diagnostic advantages, suggesting that the topic resonates with professionals interested in endoscopy and gastric health.
Several comments reference the study's methodology and implications, like noting the accuracy of the non-invasive assessment and its role in reducing biopsies, demonstrating thoughtful engagement.
Discussions reflect a perception that the study could significantly influence diagnostic approaches, especially in early detection and management of gastric cancer, though this is acknowledged moretentatively than as a definitive change.
Abstract in brief
- The study validates a non-invasive endoscopic method called EGGIM, which uses narrowband imaging during gastroscopy to grade gastric intestinal metaplasia (GIM) and assess gastric cancer risk, potentially reducing the need for biopsies.
- The research involved 250 patients from two centers, comparing the EGGIM score to the traditional gold standard, the Operative Link on Gastric Intestinal Metaplasia (OLGIM), and found that EGGIM accurately identified advanced GIM with a high area under the curve (AUC of 0.96).
- The findings suggest that endoscopic assessment with EGGIM can reliably determine gastric cancer risk, streamlining patient management and possibly avoiding invasive biopsies, which could improve early detection and treatment strategies.
Top posts
Most liked on X and Bluesky✳️Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) Criteria (HD - NBI) ✳️95 ℅ specificity and 89% sensitivity when score >4 ✳️Article in @endoscopyjrnl linked below #GItwitter @drkeithsiau @stevenbollipo @docdhir Picture courtesy: https://t.co/nlTctdVeXp https://t.co/KFH1oNzWRY
“Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et al. Fig. 1 Example narrow-band imaging (NBI) views of the endoscopic grading of gastric intestinal .. Find out more here: https://t.co/CulxCXVFz3 https://t.co/GsaOG6ix7p
Endoscopic grading of gastric intestinal metaplasia: a multicenter validation study. Interesting article indeed. https://t.co/il9Kcew3iJ #UEGambassador #metaplasia #endoscopy @my_ueg @ThiemeNY https://t.co/tIIcFWiubC
Otras fuentes del hilo: https://t.co/HtiBKWObmQ https://t.co/Faz7C1lMMU https://t.co/uv4yA3GT9y https://t.co/7U1rii9T3r @KargerPublisher
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
All mentions
Validation of Endoscopic Grading System for Gastric Intestinal Metaplasia
This study validates EGGIM, a non-invasive endoscopic method using narrowband imaging to grade gastric intestinal metaplasia (GIM) and assess gastric cancer risk, potentially reducing biopsies and improving early…
RT @drdeepakmadhu: ✳️Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) Criteria (HD - NBI) ✳️95 ℅ specificity and 89% sensitivi…
RT @drdeepakmadhu: ✳️Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) Criteria (HD - NBI) ✳️95 ℅ specificity and 89% sensitivi…
RT @drdeepakmadhu: ✳️Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) Criteria (HD - NBI) ✳️95 ℅ specificity and 89% sensitivi…
RT @drdeepakmadhu: ✳️Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) Criteria (HD - NBI) ✳️95 ℅ specificity and 89% sensitivi…
RT @drdeepakmadhu: ✳️Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) Criteria (HD - NBI) ✳️95 ℅ specificity and 89% sensitivi…
RT @drdeepakmadhu: ✳️Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) Criteria (HD - NBI) ✳️95 ℅ specificity and 89% sensitivi…
RT @drdeepakmadhu: ✳️Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) Criteria (HD - NBI) ✳️95 ℅ specificity and 89% sensitivi…
✳️Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) Criteria (HD - NBI) ✳️95 ℅ specificity and 89% sensitivity when score >4 ✳️Article in @endoscopyjrnl linked below #GItwitter @drkeithsiau @stevenbollipo @docdhir Picture courtesy: https://t.co/nlTctdVeXp https://t.co/KFH1oNzWRY
RT @aegastro: Otras fuentes del hilo: https://t.co/HtiBKWObmQ https://t.co/Faz7C1lMMU https://t.co/uv4yA3GT9y https://t.co/7U1rii9T3r…
Otras fuentes del hilo: https://t.co/HtiBKWObmQ https://t.co/Faz7C1lMMU https://t.co/uv4yA3GT9y https://t.co/7U1rii9T3r @KargerPublisher
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
RT @KralJan: Endoscopic grading of gastric intestinal metaplasia: a multicenter validation study. Interesting article indeed. https://t.co…
Endoscopic grading of gastric intestinal metaplasia: a multicenter validation study. Interesting article indeed. https://t.co/il9Kcew3iJ #UEGambassador #metaplasia #endoscopy @my_ueg @ThiemeNY https://t.co/tIIcFWiubC
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
RT @endoscopyjrnl: “Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et a…
“Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study“ by Gianluca Esposito et al. Fig. 1 Example narrow-band imaging (NBI) views of the endoscopic grading of gastric intestinal .. Find out more here: https://t.co/CulxCXVFz3 https://t.co/GsaOG6ix7p
RT @jocamaga1974: La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos…
RT @jocamaga1974: La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos…
RT @jocamaga1974: La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos…
RT @jocamaga1974: La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos…
RT @jocamaga1974: La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos…
RT @jocamaga1974: La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos…
RT @jocamaga1974: La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos…
RT @jocamaga1974: La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos…
RT @jocamaga1974: La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos…
RT @jocamaga1974: La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos…
La #endoscopia con #NBI puede diagnosticar casi 90% de los casos con MI extensa (OLGIM III/IV). Podríamos seguir a estos pacientes con riesgo de #cáncer #gastrico sin tomar biopsias
use of an endoscopic approach to grading gastric intestinal @metaplasia to determine the risk of #gastric #cancer without the need for biopsies https://t.co/WVrA5o89ci
JM
DM
EJ
JK
A
MM
SF
GE
GC
DC
MK
DP
MG
DN
TI
JM
AG
UG
RN
MM
MT
G
AA
MR
AO
VB
RJ
LR
DL
JC
FR
NG
BR